Cid Ruzafa, J., Merinopoulou, E., Baggaley, R. F., Leighton, P., Werther, W., Felici, D., & Cox, A. (2016). Patient population with multiple myeloma and transitions across different lines of therapy in the USA: An epidemiologic model. Pharmacoepidemiology & Drug Safety, 25(8), 871. https://doi.org/10.1002/pds.3927
Chicago Style (17th ed.) CitationCid Ruzafa, Javier, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici, and Andrew Cox. "Patient Population with Multiple Myeloma and Transitions Across Different Lines of Therapy in the USA: An Epidemiologic Model." Pharmacoepidemiology & Drug Safety 25, no. 8 (2016): 871. https://doi.org/10.1002/pds.3927.
MLA (9th ed.) CitationCid Ruzafa, Javier, et al. "Patient Population with Multiple Myeloma and Transitions Across Different Lines of Therapy in the USA: An Epidemiologic Model." Pharmacoepidemiology & Drug Safety, vol. 25, no. 8, 2016, p. 871, https://doi.org/10.1002/pds.3927.